Baltimore, MD – According to filings with the U.S. Securities and Exchange Commission, Galen Robotics is raising $15,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Bruce Lichorowic played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Galen Robotics
The mission of Galen Robotics is to make surgeons lives easier through assistive technology in the operating room. To fulfill that vision, the company has developed a surgical robotic platform intended to fill unserved needs in the current surgical robotics market, including neurosurgery, otolaryngology, tissue reconstruction, intrauterine brain, and spine surgery. The Galen platform is designed to work with standard surgical instruments, improving stability and ergonomics in a variety of narrow corridor and minimally invasive procedures. Galen Robotics recently filed for clearance with the FDA for the first of many anticipated indications for the platform. Upon clearance, the company expects to be the first to launch a surgical robotic platform as a service.

To learn more about Galen Robotics, visit http://www.galenrobotics.com/

Contact:
Bruce Lichorowic, Chief Executive Officer
408-502-5960

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved